aod9604 clinical trials efficacy weight loss fat loss side effects Obesity Pharmacotherapy: Current Perspectives and Future Directions AOD 9604 With Retatrutide: Evidence,
Description
Most users feel a clear lift within days
Koppe T, Patchen B, Cheng A, Bhasin M, Vulpe C, Schwartz RE, Moreno-navarrete JM, Fernandez-real JM, Pissios P, Fraenkel PG (2017) Nicotinamide N -methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes
Adding AOD 9604 targeted fat breakdown may shift this ratio even further toward preferential fat loss, though controlled studies of the combination are limited
User reports consistently mention mild headaches, particularly during the first week or two of use
